Common Side Reactions in SPPS
Understand common side reactions in solid-phase peptide synthesis, including aggregation, incomplete coupling, deletion sequences, racemization and aspartimide formation, with practical approaches for difficult peptide synthesis.
Common problems in Fmoc solid-phase peptide synthesis include stereochemical changes during amino acid activation, aspartimide formation in susceptible Asp-containing sequences, and deletion products caused by incomplete chain assembly. These problems have different origins and require different control strategies.
Resin-bound peptide aggregation can reduce access to reactive sites and contribute to incomplete coupling or deprotection. It is a physical assembly problem rather than a chemical side reaction. We recommend distinguishing these mechanisms before changing synthesis conditions: a strategy that improves chain accessibility may not prevent epimerization or aspartimide formation.
This guide focuses on these selected problems, the analytical observations that may suggest them, and the limits of common troubleshooting approaches.
Why Peptide Aggregation Matters in SPPS
Aggregation of resin-bound peptide chains is one of the major causes of difficult solid-phase synthesis. Hydrogen bonding, hydrophobic interactions and local secondary structure can bring neighboring peptide chains into close association. As aggregation develops, resin swelling and reagent diffusion may decrease, making some reactive sites less accessible to activated amino acids or deprotection reagents.
This explains why peptide length alone is not a reliable measure of synthesis difficulty. A relatively long but well-solvated sequence may assemble efficiently, while a much shorter hydrophobic or aggregation-prone peptide can become problematic early in chain elongation. Resin loading, solvent environment, amino acid composition and protecting-group strategy can all influence this behavior.
Incomplete Coupling and Deletion Sequences
Incomplete coupling becomes particularly important because SPPS is an iterative process. If an amino acid is incorporated into only part of the resin-bound peptide population, the unreacted chains may continue through subsequent synthesis cycles. The final crude product can therefore contain peptides that are nearly identical to the desired sequence but lack one or more residues.
These deletion sequences may be difficult to remove because their charge, molecular size and hydrophobicity can remain similar to those of the target peptide. A relatively small synthesis problem can therefore become a much more difficult purification problem later.
This is an important practical consideration in peptide manufacturing: final HPLC purification cannot always compensate efficiently for poor chain assembly. Improving crude peptide quality during synthesis can reduce purification complexity, solvent consumption and loss of target material during fraction collection.
Racemization and Epimerization During Amino Acid Activation
Activation and coupling conditions can alter amino acid stereochemistry. When one stereocenter changes within a peptide containing several stereocenters, the resulting product is an epimer of the intended peptide. Cysteine and histidine deserve particular attention because their susceptibility depends on the protecting group and reaction conditions.
In a study of microwave-enhanced Fmoc-SPPS, reducing the coupling temperature for cysteine and histidine reduced racemization. This supports evaluating sensitive residues separately when developing a heated synthesis method; it does not establish a universal temperature or coupling protocol for every peptide. Palasek et al., Limiting racemization and aspartimide formation.
An epimer has the same molecular formula and molecular mass as the intended peptide. Intact-mass agreement therefore cannot establish stereochemical purity. Additional chromatographic peaks may justify investigation, but retention time alone does not identify an epimer.
We recommend reviewing activation, base exposure and temperature at susceptible steps, then checking the outcome with an analytical approach capable of addressing the suspected stereochemical change.
Aspartimide Formation in Asp-Containing Sequences
During Fmoc-SPPS, basic conditions can promote cyclization involving an Asp side chain and the following backbone amide, producing an aspartimide intermediate. Subsequent reactions can generate several related impurities. The extent of this chemistry depends on the sequence and synthesis conditions.
A systematic study of Asp–Xaa model peptides demonstrated that the residue following Asp and its protection state influenced byproduct formation. Alternative Asp side-chain protection and milder Fmoc-cleavage conditions reduced the problem in the studied systems. These findings support sequence-specific optimization rather than assuming that one protecting group prevents aspartimide formation in every peptide. Mergler et al., The aspartimide problem in Fmoc-based SPPS. Part II.
When Asp-related impurities are suspected, review the local sequence, protecting-group strategy and deprotection conditions together. A modified procedure must still achieve adequate Fmoc removal and subsequent coupling. Assigning an impurity as aspartimide-related requires appropriate analytical evidence; a complex HPLC profile alone is insufficient.
Distinguishing Side Reactions from Incomplete Chain Assembly
Different mechanisms can produce similar analytical observations. Use the following distinctions to guide further investigation; none of these observations alone establishes the identity of an impurity.
| Problem | Mechanistic distinction | Observation that may prompt investigation | What to review |
|---|---|---|---|
| Racemization or epimerization | A change in residue stereochemistry | Additional chromatographic components despite agreement with the expected intact mass | Activation and coupling conditions at susceptible residues; analytical discrimination of stereoisomers |
| Aspartimide formation | Chemical transformation involving a susceptible Asp-containing sequence | Byproducts associated with the local Asp sequence and deprotection conditions | Asp protection, neighboring residues and the Fmoc-removal procedure |
| Incomplete coupling or deprotection | Failure to complete an intended assembly step | Truncated or deletion-containing products | The specific coupling or deprotection step and access to reactive sites |
| Resin-bound aggregation | Physical association of growing peptide chains | Reduced reaction efficiency as the sequence grows | Resin environment, loading, solvation and sequence-dependent aggregation |
The first two entries concern chemical side reactions; the latter two distinguish incomplete assembly from a physical factor that can contribute to it. Changes should be evaluated against both reaction completion and the resulting impurity profile.
Literature Case Study: Pediocin PA-1
A useful example is the chemical synthesis of pediocin PA-1, a 44-residue antimicrobial peptide containing two disulfide bonds. In a published study, the first attempt to prepare its linear precursor by standard stepwise Fmoc-SPPS produced a complex mixture of shorter peptides rather than the desired full-length product.
The researchers did not simply increase coupling time throughout the synthesis. Instead, C-terminal ladder sequences were prepared and analyzed by LC-MS to identify where chain assembly was failing. The analysis showed that incorporation of Fmoc-Asn(Trt)-OH following Gly29 was ineffective.
Pseudoproline-containing building blocks were subsequently introduced at selected positions to help reduce aggregation during peptide elongation. Combined with HMPB-ChemMatrix resin chemistry, the optimized strategy produced the linear pediocin precursor with approximately 70–80% crude purity after cleavage and side-chain deprotection.
This case illustrates an important principle in difficult peptide synthesis: locating the region where chain assembly begins to deteriorate can be more useful than globally applying stronger conditions to the entire sequence.
Practical Strategies for Difficult Peptides
Once the problematic region is identified, synthesis conditions can be adjusted more selectively. Depending on the sequence, useful approaches may include lower resin loading, PEG-containing resins, double coupling at selected positions, alternative coupling reagents, optimized solvent systems and carefully controlled temperature.
For aggregation-prone sequences, pseudoproline, backbone-protection and depsipeptide strategies can temporarily disrupt backbone interactions and improve accessibility of the growing chain. The objective is not simply to increase reaction strength, but to address the physical or chemical reason that a particular region is difficult to synthesize.
Crude HPLC and LC-MS are therefore useful not only as final quality-control methods but also as tools for understanding synthesis performance. Improving crude quality generally creates a more favorable starting point for downstream peptide purification by RP-HPLC.
Conclusion
Many SPPS failures are chemically understandable. Aggregation can restrict reagent accessibility, incomplete reactions can produce deletion sequences, and sensitive residues may undergo racemization or aspartimide formation. Effective troubleshooting therefore depends on understanding where the synthesis becomes difficult and what chemical or physical factor is responsible.
For an introduction to the complete synthesis process, see Solid-Phase Peptide Synthesis (SPPS): A Practical Guide. Alan Scientific also provides custom peptide synthesis for difficult, long, modified and non-standard peptide sequences.
References
1. Coin I, Beyermann M, Bienert M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences.Nature Protocols. 2007;2:3247–3256. doi:10.1038/nprot.2007.454.
2. Krchnák V, Flegelová Z, Vágner J. Aggregation of resin-bound peptides during solid-phase peptide synthesis: prediction of difficult sequences.International Journal of Peptide and Protein Research. 1993;42(5):450–454. doi:10.1111/j.1399-3011.1993.tb00153.x.
3. Tickler AK, Wade JD. Overview of solid phase synthesis of difficult peptide sequences.Current Protocols in Protein Science. 2007;Chapter 18:Unit 18.8. doi:10.1002/0471140864.ps1808s50.
4. Bédard F, Hammami R, Zirah S, Rebuffat S, Fliss I, Biron E, et al. Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.Scientific Reports. 2018;8:9029. doi:10.1038/s41598-018-27225-3.
5. Palasek et al. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. DOI: 10.1002/psc.804.
6. Mergler et al. The aspartimide problem in Fmoc-based SPPS. Part II. DOI: 10.1002/psc.473.